MEDS peer analysis
DataMeds AI (MEDS) against its competitors: price, today's move, 1-year return and market value side by side.
MEDS and its peers
| Company | Price | Today | 1-year return | Market cap |
|---|---|---|---|---|
| ALGS Aligos Therapeutics | $1.25 | -3.85% | -84.81% | $7.81M |
| BDSX Biodesix | $8.30 | -1.19% | 20.29% | $92.03M |
| BEAT Heartbeam | $0.31 | -9.25% | -81.39% | $19.56M |
| INMB INmune Bio | $0.89 | -13.19% | -40.79% | $27.68M |
| OKUR OnKure Therapeutics | $2.76 | -2.13% | 0.00% | $111.79M |
| TELA TELA Bio | $0.78 | 2.36% | -33.89% | $35.25M |
| VNRX VolitionRx | $0.16 | -10.00% | -97.49% | $1.98M |
| XLO Xilio Therapeutics | $7.63 | 1.19% | -27.33% | $53.90M |
| MEDS DataMeds AI | $1.03 | 41.54% | – | $4.64M |
- MEDS's peers: ALGS (Aligos Therapeutics), BDSX (Biodesix), BEAT (Heartbeam), INMB (INmune Bio), OKUR (OnKure Therapeutics), TELA (TELA Bio), VNRX (VolitionRx), XLO (Xilio Therapeutics).
Updated 2026-11-20 09:50 UTC